VIKING GLOBAL INVESTORS LP

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 27% 68% 82%
Transactions
55 20% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 48%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
VIKING GLOBAL INVESTORS LP's trades of Inhibrx Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
38.15
Quantity 1,912,750 -100.0%
Value US$72,971,412
Transaction date
Sale
Price
38.15
Quantity 1,912,750 -100.0%
Value US$72,971,412
Transaction date
Proposed sale
Price
32.88
Quantity 6,500,000
Value US$213,720,000
US RayzeBio Inc (RYZB)
Transaction date
Purchase
Price
18.00
Quantity 458,333 +35.7%
Value US$8,249,994
US RayzeBio Inc (RYZB)
Transaction date
Purchase
Price
18.00
Quantity 930,556 +23.4%
Value US$16,750,008
US RayzeBio Inc (RYZB)
Transaction date
Purchase
Price
18.00
Quantity 458,333 +35.7%
Value US$8,249,994
US RayzeBio Inc (RYZB)
Transaction date
Purchase
Price
18.00
Quantity 930,556 +23.4%
Value US$16,750,008
US Inhibrx Inc (INBX)
Transaction date
Purchase
Price
19.35
Quantity 511,627 +inf%
Value US$9,899,982
Transaction date
Sale
Price
9.90
Quantity 2,226,195 -14.7%
Value US$22,039,330
Transaction date
Sale
Price
9.90
Quantity 5,236,006 -14.7%
Value US$51,836,459
Transaction date
Sale
Price
9.90
Quantity 5,427,043 -14.7%
Value US$53,727,726
Transaction date
Sale
Price
9.90
Quantity 110,756 -14.7%
Value US$1,096,484
US Inhibrx Inc (INBX)
Transaction date
Purchase
Price
30.00
Quantity 333,333 +inf%
Value US$9,999,957
US Inhibrx Inc (INBX)
Transaction date
Purchase
Price
30.00
Quantity 1,000,000 +70.1%
Value US$29,999,900
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-09 2025-10-07
S Sale
4,175 -4.1%
377.09
US$3,634,988 		4,175 -4.1% 377.09 US$3,634,988
2025-10-09 2025-10-07
S Sale
76,763 -39.5%
202.56
US$1,828,321 		76,763 -39.5% 202.56 US$1,828,321
2025-10-09 2025-10-07
S Sale
37,493 -30.9%
304.61
US$993,308 		37,493 -30.9% 304.61 US$993,308
2025-07-01 2025-06-27
S Sale
3,500,000 -15.9%
44.00
US$154,000,000 		3,500,000 -15.9% 44.00 US$154,000,000
2025-01-31 2025-01-31
PrS Proposed sale
3,065,616
34.90
US$106,989,998 		3,065,616 34.90 US$106,989,998
2025-01-31 2025-01-31
S Sale
3,065,616 -12.2%
34.90
US$106,989,998 		3,065,616 -12.2% 34.90 US$106,989,998
2024-06-18 2024-06-17
S Sale
39,032 -100.0%
38.15
US$1,489,071 		39,032 -100.0% 38.15 US$1,489,071
2024-06-18 2024-06-17
S Sale
1,912,750 -100.0%
38.15
US$72,971,412 		1,912,750 -100.0% 38.15 US$72,971,412
2024-06-18 2024-06-17
S Sale
39,032 -100.0%
38.15
US$1,489,071 		39,032 -100.0% 38.15 US$1,489,071
2024-06-18 2024-06-17
S Sale
1,912,750 -100.0%
38.15
US$72,971,412 		1,912,750 -100.0% 38.15 US$72,971,412
2024-03-07 2024-03-05
S Sale
60,772 -60.9%
34.25
US$2,081,441 		60,772 -60.9% 34.25 US$2,081,441
2024-03-07 2024-03-05
S Sale
2,977,845 -60.9%
34.25
US$101,991,191 		2,977,845 -60.9% 34.25 US$101,991,191
2024-03-07 2024-03-05
S Sale
60,772 -60.9%
34.25
US$2,081,441 		60,772 -60.9% 34.25 US$2,081,441
2024-03-07 2024-03-05
S Sale
2,977,845 -60.9%
34.25
US$101,991,191 		2,977,845 -60.9% 34.25 US$101,991,191
2024-01-05 2024-01-04
S Sale
540,000 -11.3%
19.53
US$10,546,200 		540,000 -11.3% 19.53 US$10,546,200
2024-01-04 2024-01-02
S Sale
3,983 -18.9%
31.30
US$124,668 		3,983 -18.9% 31.30 US$124,668
2024-01-04 2024-01-02
S Sale
195,200 -18.9%
31.30
US$6,109,760 		195,200 -18.9% 31.30 US$6,109,760
2024-01-04 2024-01-02
S Sale
6,300,817 -18.9%
31.30
US$197,215,572 		6,300,817 -18.9% 31.30 US$197,215,572
2024-01-04 2024-01-02
S Sale
3,983 -18.9%
31.30
US$124,668 		3,983 -18.9% 31.30 US$124,668
2024-01-04 2024-01-02
S Sale
195,200 -18.9%
31.30
US$6,109,760 		195,200 -18.9% 31.30 US$6,109,760
2024-01-04 2024-01-02
S Sale
6,300,817 -18.9%
31.30
US$197,215,572 		6,300,817 -18.9% 31.30 US$197,215,572
2024-01-02 2024-01-02
PrS Proposed sale
6,500,000
32.88
US$213,720,000 		6,500,000 32.88 US$213,720,000
2023-09-21 2023-09-19
US RayzeBio Inc (RYZB)
B Purchase
458,333 +35.7%
18.00
US$8,249,994 		458,333 +35.7% 18.00 US$8,249,994
2023-09-21 2023-09-19
US RayzeBio Inc (RYZB)
B Purchase
930,556 +23.4%
18.00
US$16,750,008 		930,556 +23.4% 18.00 US$16,750,008
2023-09-21 2023-09-19
US RayzeBio Inc (RYZB)
B Purchase
458,333 +35.7%
18.00
US$8,249,994 		458,333 +35.7% 18.00 US$8,249,994
2023-09-21 2023-09-19
US RayzeBio Inc (RYZB)
B Purchase
930,556 +23.4%
18.00
US$16,750,008 		930,556 +23.4% 18.00 US$16,750,008
2023-08-30 2023-08-28
US Inhibrx Inc (INBX)
B Purchase
511,627 +inf%
19.35
US$9,899,982 		511,627 +inf% 19.35 US$9,899,982
2023-07-19 2023-07-18
S Sale
1,500,000 -5.6%
35.00
US$52,500,000 		1,500,000 -5.6% 35.00 US$52,500,000
2023-06-26 2023-06-22
S Sale
2,226,195 -14.7%
9.90
US$22,039,330 		2,226,195 -14.7% 9.90 US$22,039,330
2023-06-26 2023-06-22
S Sale
5,236,006 -14.7%
9.90
US$51,836,459 		5,236,006 -14.7% 9.90 US$51,836,459
2023-06-26 2023-06-22
S Sale
5,427,043 -14.7%
9.90
US$53,727,726 		5,427,043 -14.7% 9.90 US$53,727,726
2023-06-26 2023-06-22
S Sale
110,756 -14.7%
9.90
US$1,096,484 		110,756 -14.7% 9.90 US$1,096,484
2023-05-11 2023-05-09
B Purchase
850,000 +21.6%
16.00
US$13,600,000 		850,000 +21.6% 16.00 US$13,600,000
2022-11-04 2022-11-02
B Purchase
279,530 +30.0%
10.08
US$2,817,662 		279,530 +30.0% 10.08 US$2,817,662
2022-11-04 2022-11-02
B Purchase
567,532 +30.0%
10.08
US$5,720,723 		567,532 +30.0% 10.08 US$5,720,723
2022-10-12 2022-10-07
US Inhibrx Inc (INBX)
B Purchase
333,333 +inf%
30.00
US$9,999,957 		333,333 +inf% 30.00 US$9,999,957
2022-10-12 2022-10-07
US Inhibrx Inc (INBX)
B Purchase
1,000,000 +70.1%
30.00
US$29,999,900 		1,000,000 +70.1% 30.00 US$29,999,900
2022-09-09 2022-09-09
S Sale
3,142 -0.2%
31.44
US$98,792 		3,142 -0.2% 31.44 US$98,792
2022-09-09 2022-09-09
S Sale
73,886 -3.8%
30.90
US$2,282,804 		73,886 -3.8% 30.90 US$2,282,804
2022-09-09 2022-09-09
S Sale
147,502 -7.1%
29.87
US$4,405,545 		147,502 -7.1% 29.87 US$4,405,545
2022-09-09 2022-09-09
S Sale
6,654 -0.2%
31.44
US$209,218 		6,654 -0.2% 31.44 US$209,218
2022-09-09 2022-09-09
S Sale
156,463 -3.8%
30.90
US$4,834,128 		156,463 -3.8% 30.90 US$4,834,128
2022-09-09 2022-09-09
S Sale
312,353 -7.1%
29.87
US$9,329,266 		312,353 -7.1% 29.87 US$9,329,266
2022-09-09 2022-09-08
S Sale
52,466 -2.5%
32.23
US$1,690,958 		52,466 -2.5% 32.23 US$1,690,958
2022-09-09 2022-09-08
S Sale
7,554 -0.4%
30.59
US$231,058 		7,554 -0.4% 30.59 US$231,058